6-[4-amino-5-(2,6-difluoro-benzoyl)-thiazol-2-ylamino]-N-(pyridin-2-ylmethyl)-nicotinamide

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 6-[4-amino-5-(2,6-difluoro-benzoyl)-thiazol-2-ylamino]-N-(pyridin-2-ylmethyl)-nicotinamide
• 英文别名: 6-[[4-amino-5-(2,6-difluorobenzoyl)-1,3-thiazol-2-yl]amino]-N-(pyridin-2-ylmethyl)pyridine-3-carboxamide
• 化学式: C₂₂H₁₆F₂N₆O₂S
• 分子量: 466.471
• InChiKey: FADFHDPZXCUMLS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  33
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  151
• 氢给体数：
  3
• 氢受体数：
  10

文献信息

• [EN] ANTIPROLIFERATIVE 2-(HETEROARYL)-AMINOTHIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE<br/>[FR] COMPOSES 2-(HETEROARYL)-AMINOTHIAZOLE ANTIPROLIFERATIFS, COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCEDES D'UTILISATION
  申请人：PFIZER

  公开号：WO2004014904A1

  公开（公告）日：2004-02-19

  Compounds represented by the Formula (I): are described. The compounds and pharmaceutical compositions containing them may be used in inhibiting and/or modulating protein kinases, in treating or preventing diseases associated with protein kinases, and/or in treating or preventing cellular proliferative diseases.

  由式（I）表示的化合物已被描述。这些化合物及含有它们的药物组合物可用于抑制和/或调节蛋白激酶，在治疗或预防与蛋白激酶相关的疾病，以及/或在治疗或预防细胞增殖性疾病方面。
• Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and methods for their use
  申请人：Chong Kwan Mung Wesley

  公开号：US20050038078A1

  公开（公告）日：2005-02-17

  Compounds represented by the Formula (I): are described. The compounds and pharmaceutical compositions containing them may be used in inhibiting and/or modulating protein kinases, in treating or preventing diseases associated with protein kinases, and/or in treating or preventing cellular proliferative diseases.

  由化学式(I)代表的化合物被描述。这些化合物和含有它们的药物组合物可用于抑制和/或调节蛋白激酶，在治疗或预防与蛋白激酶相关的疾病，以及/或在治疗或预防细胞增殖性疾病方面。
• Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and method for their use
  申请人：Chong Kwan Mung Wesley

  公开号：US20050176773A1

  公开（公告）日：2005-08-11

  Compounds represented by the Formula (I): are described. The compounds and pharmaceutical compositions containing them may be used in inhibiting and/or modulating protein kinases, in treating or preventing diseases associated with protein kinases, and/or in treating or preventing cellular proliferative diseases.

  描述了由公式（I）表示的化合物。这些化合物和含有它们的药物组合物可用于抑制和/或调节蛋白激酶，在治疗或预防与蛋白激酶相关的疾病以及/或治疗或预防细胞增殖性疾病方面使用。